{"entity":{"type":"insider","cik":"0001280238","url":"/insider/0001280238","json_url":"/insider/0001280238.json","name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":12,"first":"2004-10-19","last":"2014-02-05","span_basis":"filed_date"},"name_variants":[{"name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC","source":"filing","n_filings":12,"first_seen":"2004-10-19","last_seen":"2014-02-05"}],"transactions":[{"id":6344652,"accession":"0001209191-14-007595","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-14-007595","line_url":"/filing/0001209191-14-007595","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD","owner_display_name":"ALTA BIOPHARMA PARTNERS III LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":112817.0,"shares_display":"112,817","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1240987.0,"total_display":"1,240,987.00","total_whole":"1,240,987","shares_owned_after":1753447.0,"shares_owned_after_display":"1,753,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-05","scope":"insider","n_lines":3},{"id":2163996,"accession":"0001209191-12-049852","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-12-049852","line_url":"/filing/0001209191-12-049852","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; HURWITZ EDWARD; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; Kiley Alison","owner_display_name":"ALTA BIOPHARMA PARTNERS III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140000.0,"shares_display":"140,000","price_per_share":18.67,"price_display":"18.67","price_state":"stated","total_value":2613800.0,"total_display":"2,613,800.00","total_whole":"2,613,800","shares_owned_after":2280197.0,"shares_owned_after_display":"2,280,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-16","filed_date":"2012-10-17","scope":"insider","n_lines":3},{"id":2163985,"accession":"0001209191-12-049852","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-049852","line_url":"/filing/0001209191-12-049852","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; HURWITZ EDWARD; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; Kiley Alison","owner_display_name":"ALTA BIOPHARMA PARTNERS III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60733.0,"shares_display":"60,733","price_per_share":17.54,"price_display":"17.54","price_state":"stated","total_value":1065256.82,"total_display":"1,065,256.82","total_whole":"1,065,257","shares_owned_after":2408426.0,"shares_owned_after_display":"2,408,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-15","filed_date":"2012-10-17","scope":"insider","n_lines":3},{"id":9018918,"accession":"0001209191-11-043220","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-11-043220","line_url":"/filing/0001209191-11-043220","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_display_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":12.454,"price_display":"12.45","price_state":"stated","total_value":68497.0,"total_display":"68,497.00","total_whole":"68,497","shares_owned_after":2464052.0,"shares_owned_after_display":"2,464,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-09","scope":"insider","n_lines":3},{"id":9018915,"accession":"0001209191-11-043220","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-043220","line_url":"/filing/0001209191-11-043220","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_display_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4200.0,"shares_display":"4,200","price_per_share":12.4296,"price_display":"12.43","price_state":"stated","total_value":52204.32,"total_display":"52,204.32","total_whole":"52,204","shares_owned_after":2459014.0,"shares_owned_after_display":"2,459,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-08","filed_date":"2011-08-09","scope":"insider","n_lines":3},{"id":7564676,"accession":"0001209191-10-051904","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-10-051904","line_url":"/filing/0001209191-10-051904","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; PENHOET EDWARD; HURWITZ EDWARD","owner_display_name":"CHAMPSI FARAH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":315789.0,"shares_display":"315,789","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":2999995.5,"total_display":"2,999,995.50","total_whole":"2,999,996","shares_owned_after":2455167.0,"shares_owned_after_display":"2,455,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-27","filed_date":"2010-10-27","scope":"insider","n_lines":3},{"id":7244333,"accession":"0001209191-10-036944","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-10-036944","line_url":"/filing/0001209191-10-036944","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"PENHOET EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; DELEAGE JEAN; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_display_name":"PENHOET EDWARD","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11912224.0,"shares_display":"11,912,224","price_per_share":0.275,"price_display":"0.28","price_state":"stated","total_value":3275861.6,"total_display":"3,275,861.60","total_whole":"3,275,862","shares_owned_after":10910596.0,"shares_owned_after_display":"10,910,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-30","filed_date":"2010-07-02","scope":"insider","n_lines":3},{"id":5638085,"accession":"0001209191-09-057467","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-057467","line_url":"/filing/0001209191-09-057467","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; DELEAGE JEAN; PENHOET EDWARD; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_display_name":"ALTA BIOPHARMA MANAGEMENT III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stocks","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2232464.0,"shares_display":"2,232,464","price_per_share":2.0094,"price_display":"2.01","price_state":"stated","total_value":4485913.1616,"total_display":"4,485,913.16","total_whole":"4,485,913","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-14","filed_date":"2009-12-16","scope":"insider","n_lines":3},{"id":5711657,"accession":"0001209191-09-047812","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-047812","line_url":"/filing/0001209191-09-047812","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"HURWITZ EDWARD; PENHOET EDWARD; DELEAGE JEAN; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA BIOPHARMA MANAGEMENT III LLC; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP","owner_display_name":"HURWITZ EDWARD","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":261780.0,"shares_display":"261,780","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":499999.8,"total_display":"499,999.80","total_whole":"500,000","shares_owned_after":1439921.0,"shares_owned_after_display":"1,439,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-05","filed_date":"2009-10-06","scope":"insider","n_lines":3},{"id":5665673,"accession":"0001209191-09-043545","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_display_name":"ALTA BIOPHARMA PARTNERS III LP","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":422275.0,"shares_display":"422,275","price_per_share":0.2195,"price_display":"0.22","price_state":"stated","total_value":92689.3625,"total_display":"92,689.36","total_whole":"92,689","shares_owned_after":853026.0,"shares_owned_after_display":"853,026","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-08","filed_date":"2009-09-08","scope":"insider","n_lines":6},{"id":5665667,"accession":"0001209191-09-043545","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_display_name":"ALTA BIOPHARMA PARTNERS III LP","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":295562.0,"shares_display":"295,562","price_per_share":0.2327,"price_display":"0.23","price_state":"stated","total_value":68777.2774,"total_display":"68,777.28","total_whole":"68,777","shares_owned_after":1091282.0,"shares_owned_after_display":"1,091,282","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-03","filed_date":"2009-09-08","scope":"insider","n_lines":6},{"id":1704010,"accession":"0001209191-05-052708","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-052708","line_url":"/filing/0001209191-05-052708","is_derivative":false,"issuer_cik":"0001138812","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001138812","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA CALIFORNIA MANAGEMENT PARTNERS III LLC; ALTA CALIFORNIA PARTNERS III LP; JANNEY DANIEL; ALTA EMBARCADERO PARTNERS III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_display_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166937.0,"shares_display":"166,937","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":2170181.0,"total_display":"2,170,181.00","total_whole":"2,170,181","shares_owned_after":869164.0,"shares_owned_after_display":"869,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-14","filed_date":"2005-10-18","scope":"insider","n_lines":3},{"id":1232220,"accession":"0001209191-05-052402","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-052402","line_url":"/filing/0001209191-05-052402","is_derivative":false,"issuer_cik":"0001138812","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001138812","owner_cik":null,"owner_name":"ALTA CALIFORNIA MANAGEMENT PARTNERS III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA CALIFORNIA PARTNERS III LP; JANNEY DANIEL; ALTA EMBARCADERO PARTNERS III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_display_name":"ALTA CALIFORNIA MANAGEMENT PARTNERS III LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":247314.0,"shares_display":"247,314","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":3215082.0,"total_display":"3,215,082.00","total_whole":"3,215,082","shares_owned_after":1022064.0,"shares_owned_after_display":"1,022,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-12","filed_date":"2005-10-14","scope":"insider","n_lines":3},{"id":9258772,"accession":"0001209191-04-049151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-04-049151","line_url":"/filing/0001209191-04-049151#line-1","is_derivative":false,"issuer_cik":"0001257444","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001257444","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA BIOPHARMA PARTNERS III LP; ALTA CALIFORNIA MANAGEMENT PARTNERS III LLC; ALTA CALIFORNIA PARTNERS III LP; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA EMBARCADERO PARTNERS III LLC; JANNEY DANIEL","owner_display_name":"ALTA BIOPHARMA MANAGEMENT III LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":358426.0,"shares_display":"358,426","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2150556.0,"total_display":"2,150,556.00","total_whole":"2,150,556","shares_owned_after":2363263.0,"shares_owned_after_display":"2,363,263","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-10-15","filed_date":"2004-10-21","scope":"insider"},{"id":613682,"accession":"0001209191-04-048864","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-04-048864","line_url":"/filing/0001209191-04-048864#line-3","is_derivative":false,"issuer_cik":"0001138812","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001138812","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; JANNEY DANIEL; ALTA CALIFORNIA MANAGEMENT PARTNERS III LLC; ALTA BIOPHARMA PARTNERS III LP; ALTA CALIFORNIA PARTNERS III LP; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO PARTNERS III LLC","owner_display_name":"ALTA BIOPHARMA MANAGEMENT III LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":416666.0,"shares_display":"416,666","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2499996.0,"total_display":"2,499,996.00","total_whole":"2,499,996","shares_owned_after":2421503.0,"shares_owned_after_display":"2,421,503","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-10-15","filed_date":"2004-10-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001346830","name":"Cara Therapeutics, Inc.","url":"/issuer/0001346830","role":"Ten percent owner","n_filings":1,"first_seen":"2014-02-05","last_seen":"2014-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001338042","name":"Aegerion Pharmaceuticals, Inc.","url":"/issuer/0001338042","role":"Ten percent owner","n_filings":3,"first_seen":"2010-10-27","last_seen":"2012-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001061027","name":"SUNESIS PHARMACEUTICALS INC","url":"/issuer/0001061027","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2009-12-16","last_seen":"2010-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001183765","name":"THRESHOLD PHARMACEUTICALS INC","url":"/issuer/0001183765","role":"Other","n_filings":1,"first_seen":"2009-10-06","last_seen":"2009-10-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001070698","name":"TorreyPines Therapeutics, Inc.","url":"/issuer/0001070698","role":"Other","n_filings":1,"first_seen":"2009-09-08","last_seen":"2009-09-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001138812","name":"COTHERIX INC","url":"/issuer/0001138812","role":"Ten percent owner","n_filings":4,"first_seen":"2004-10-19","last_seen":"2005-10-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001280238","retrieved_at":"2026-08-24T01:38:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}